To test whether SLC38A2 acts in a tumour-intrinsic manner or requires the immune system for its in vivo effects, we examined growth of SLC38A2-deficient MC38 tumours in Batf3–/– or Rag1–/– mice. This evidence concerns the gene RAG1 and neoplasm.